| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/25/2001 | WO2001079837A1 Methylxanthines in the diagnosis and treatment of autistic disorder |
| 10/25/2001 | WO2001079830A2 A system and method to determine thermophysical properties of multi-component gas |
| 10/25/2001 | WO2001079828A1 Device and method for determining characteristics of a biomass |
| 10/25/2001 | WO2001079826A1 Method for selective determination of the concentration of detrimental impurities and device for carrying out said method |
| 10/25/2001 | WO2001079821A1 Grid-waveguide structure for reinforcing an excitation field and use thereof |
| 10/25/2001 | WO2001079816A1 Method in connection with the production of pulp, paper or paperboard |
| 10/25/2001 | WO2001079814A1 Device for evaluating internal quality of vegetable or fruit, method for warm-up operation of the device, and method for measuring internal quality |
| 10/25/2001 | WO2001079809A1 Method for analysing measured gas |
| 10/25/2001 | WO2001079807A1 Filtering device |
| 10/25/2001 | WO2001079805A1 Gas sampling apparatus |
| 10/25/2001 | WO2001079562A1 Aptamer based two-site binding assay |
| 10/25/2001 | WO2001079559A1 System to detect protein-protein interactions |
| 10/25/2001 | WO2001079557A2 Gtp-binding protein useful in treatment and detection of cancer |
| 10/25/2001 | WO2001079550A2 Genetic testing for determining the risk of pouchitis development |
| 10/25/2001 | WO2001079548A2 Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction |
| 10/25/2001 | WO2001079539A2 Method for using transfectable constructions from luciferase and from the promotor of the human period 1 gene for identifying novel active substances that influence the day/night rhythm and sleep |
| 10/25/2001 | WO2001079534A1 A method of detecting neoplastic or non-neoplastic cells |
| 10/25/2001 | WO2001079531A1 Early diagnosis of miscarriage in human beings |
| 10/25/2001 | WO2001079529A1 Biosensor and related method |
| 10/25/2001 | WO2001079527A2 Sexual fidelity and sex crime verification |
| 10/25/2001 | WO2001079526A2 Live cell procedures to identify compounds modulating intracellular distribution of phosphodiesterase (pde) enzymes |
| 10/25/2001 | WO2001079525A2 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 10/25/2001 | WO2001079523A2 Method and system for microorganism identification by mass spectrometry-based proteome database searching |
| 10/25/2001 | WO2001079522A2 Screening assay methods and systems using target pooling |
| 10/25/2001 | WO2001079493A1 New lipid binding protein 2 |
| 10/25/2001 | WO2001079492A2 Lipid binding protein 3 |
| 10/25/2001 | WO2001079484A2 Method for detecting iodized thyroglobulin in human serum after thyroid ablation |
| 10/25/2001 | WO2001079479A2 Methods for selective targeting |
| 10/25/2001 | WO2001079468A2 Drug metabolizing enzymes |
| 10/25/2001 | WO2001079448A2 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 10/25/2001 | WO2001079420A2 Detection and amplification or rna using target-mediated ligation of dna by rna ligase |
| 10/25/2001 | WO2001079291A2 Secreted proteins |
| 10/25/2001 | WO2001079287A2 Steatosis-modulating factors and uses thereof |
| 10/25/2001 | WO2001079283A1 Modulating cell survival by modulating huntingtin function |
| 10/25/2001 | WO2001079282A2 Molecules associated with human reproduction |
| 10/25/2001 | WO2001079281A1 Sheep lice, bovicola ovis, allergen treatment |
| 10/25/2001 | WO2001079269A2 Lipid binding protein 4 |
| 10/25/2001 | WO2001079266A1 Antibody against human kgfr |
| 10/25/2001 | WO2001079265A1 Antibody against human kgf |
| 10/25/2001 | WO2001079253A1 Extracellular matrix polynucleotides, polypeptides, and antibodies |
| 10/25/2001 | WO2001079249A2 Peptide nucleic acid derivatives with a negative charge, agents and methods for producing them |
| 10/25/2001 | WO2001079216A2 Polyamide nucleic acid derivatives, agents and methods for producing them |
| 10/25/2001 | WO2001078889A2 A method of fabricating coded particles |
| 10/25/2001 | WO2001078796A1 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
| 10/25/2001 | WO2001078778A1 USE OF INHIBITION OF A Gas6 FUNCTION OR OF A Gas6 RECEPTOR FOR PREVENTING AND TREATING A CARDIOVASCULAR DISEASE |
| 10/25/2001 | WO2001078770A1 Inhibition of transmission of tick-borne infections |
| 10/25/2001 | WO2001078721A1 Aβ42 LOWERING AGENTS |
| 10/25/2001 | WO2001078708A1 Treating graft rejection with cxcr3 inhibitors |
| 10/25/2001 | WO2001078515A1 Method and apparatus for removing fat from meat cuts |
| 10/25/2001 | WO2001078498A1 Sample liquid analyzing apparatus for nutriculture |
| 10/25/2001 | WO2001064105A9 Combined lancet and electrochemical analyte-testing apparatus |
| 10/25/2001 | WO2001044500A8 Method and device for fluid quality measurement |
| 10/25/2001 | WO2001040499A3 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 10/25/2001 | WO2001039786A3 New uses of suppressive macrophage activation factors |
| 10/25/2001 | WO2001038584A3 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| 10/25/2001 | WO2001033220A3 The use of the area postreama to identify therapeutic compounds |
| 10/25/2001 | WO2001027611A3 Multiplex cytokine analysis |
| 10/25/2001 | WO2001027159A3 Polypeptides for detection and elimination of ca19-9 antigen positive cells |
| 10/25/2001 | WO2001025794A3 Protein fingerprinting by multisite labelling |
| 10/25/2001 | WO2001024328A3 Method of converting an optical wavelength with an opto-electronic laser with integrated modulator |
| 10/25/2001 | WO2001023570A3 Methods and compositions relating to sodium channel beta-1a subunits |
| 10/25/2001 | WO2001022092A3 Method to identify compounds which modulate fra-1 expression fils |
| 10/25/2001 | WO2001022091A3 Method for determining the fertility of mammals, especially of humans |
| 10/25/2001 | WO2001021838A3 Three-dimensional microarray system for parallel genotyping of single nucleotide polymorphisms |
| 10/25/2001 | WO2001021220A3 Bioprosthetic heart valves |
| 10/25/2001 | WO2001018252A3 Methods for disease detection |
| 10/25/2001 | WO2001017076A3 Tunable laser source with integrated optical amplifier |
| 10/25/2001 | WO2001016642A3 Integrated opto-electronic wavelength converter assembly |
| 10/25/2001 | WO2001012790A3 Isomerase proteins |
| 10/25/2001 | WO2001012663A3 Hematopoietic regulatory factors and methods of use thereof |
| 10/25/2001 | WO2001000805A3 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| 10/25/2001 | WO2000057187A9 Diagnosis and treatment of multiple sclerosis |
| 10/25/2001 | WO2000053812A9 Replica amplification of nucleic acid arrays |
| 10/25/2001 | WO2000047618A9 HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES |
| 10/25/2001 | WO2000047104A3 Antagonists of hmg1 for treating inflammatory conditions |
| 10/25/2001 | WO2000045178A9 Method of evaluating myelosuppressive state |
| 10/25/2001 | WO2000043492A9 Method of site specific labeling of proteins and uses therefor |
| 10/25/2001 | WO2000040967A3 Method and device for diagnosing allergy symptoms |
| 10/25/2001 | US20010034580 Methods for using functional site descriptors and predicting protein function |
| 10/25/2001 | US20010034500 Ocular analyte sensor |
| 10/25/2001 | US20010034477 Multivariate analysis of green to ultraviolet spectra of cell and tissue samples |
| 10/25/2001 | US20010034436 Polynucleotide and polypeptides, screening for antibiotic activity, Staphylococcus |
| 10/25/2001 | US20010034337 Antiproliferative agents |
| 10/25/2001 | US20010034334 Genetic engineered polypeptide |
| 10/25/2001 | US20010034331 Isolated polypeptide |
| 10/25/2001 | US20010034327 Suppression of inhibitors |
| 10/25/2001 | US20010034068 Screening device and methods of screening immunoassay tests and agglutination tests |
| 10/25/2001 | US20010034066 A dilute protein solution containing detergent such as sodium dodecyl sulfate (SDS) is treated with dilute solution of trichloroacetic acid (TCA) containing sodium or potassium salts, protein quantitatively precipitates |
| 10/25/2001 | US20010034052 A breast tumor polypeptide(s), immunogenic portions thereof, polynucleotides that encode such peptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides; vaccines |
| 10/25/2001 | US20010034038 Isolated ductal fluid sample |
| 10/25/2001 | US20010034037 Incubating a sample with a monocyte-containing reagent in a pyrogen-free assay on a surface treated with a pyrogen-free antibody to a cytokine; measuring susrface-bound cytokine to test basal production of endogenous inflammation mediators |
| 10/25/2001 | US20010034036 Qualitative and quantitative colorimetric analysis of metabolites found in body fluid; using a membrane of counterions neutralized by competing chromionophores and affinophores bound to recognition molecules; ovulation |
| 10/25/2001 | US20010034034 Chemical and biological targets having an affinity for the nanocrystal which emits upon radiation a charateristic emission spectrum analyzed spectroscopically; immunoassays; ELIZA; accuracy; noncontamination |
| 10/25/2001 | US20010034033 Nucleic acid mediated electron transfer |
| 10/25/2001 | US20010034030 Acquiring a spectrum for a hybridization complex formed between a nucleic acid probe electromagnetically coupled to a portion of a signal path and a nucleic acid target by propagating a test signal and detecting hybridization signal |
| 10/25/2001 | US20010034027 Microarray, method for producing the same, and method for correcting inter-pin spotting amount error of the same |
| 10/25/2001 | US20010034026 Ex vivo generation of functional leukemia cells in a three-dimensional bioreactor |
| 10/25/2001 | US20010034024 Mutations in and genomic structure of HERG - a long QT syndrome gene |
| 10/25/2001 | US20010034022 Providing a sample suspected of containing enterovirus and a mixed cell culture comprising Rhabdomyosarcoma cells and human mucoepidermoid cells, inoculating mixed cell culture with sample, observing inoculated culture for enterovirus |
| 10/25/2001 | US20010034021 Antibodies that specifically react with seroreactive regions on HPV 16 proteins E1 and E2 |